Back to search

Article

Antioxidant therapy in a patient with Hyperprolinemia type I presented with mild neuromotor retardation and speech disturbance

2020-12-16

Abstract excerpt

<h4>Background: </h4> Hyperprolinemia type 1 (HPI) is an autosomal recessive inborn disease caused by mutations/deletions of PRODH gene, which is located on chromosome 22q11. The clinic spectrum involves mainly delayed psychomotor development, mild-to-severe mental retardation, neuropsychiatric symptoms and epilepsy. Although HPI can easily be diagnosed in patients undergoing metabolic screening tests, there is no...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
216200f6-9b1a-57c9-b88a-083cd0edbd17
DOI
10.21203/rs.3.rs-128629/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Antioxidant therapy in a patient with Hyperprolinemia type I presented with mild neuromotor retardation and speech disturbanceDOI 10.21203/rs.3.rs-128629/v1
Select a neighboring publication to make it the new centre.